ABOUT US
Our commitment to science, health, and innovation motivates us to be always highly involved in the R+D+I project to improve people’s lives.
Our commitment to science, health, and innovation motivates us to be always highly involved in the R+D+I project to improve people’s lives.
Sabartech S.L. was founded in 2016. From that moment, it has positioned itself internationally as a leading company in the latest precision medicine technologies for the early diagnosis and personalized treatment of cancer and other pathologies.
We have a multidisciplinary team made up of scientists, biotechnologists, medical specialists, computer developers, bioinformatics, marketing, and sales that allow us to take a multi-modal approach. Our commitment to science, health, and innovation motivate us to be always too involved in the R+D+I project to improve people’s lives.
Parque Científico Universidad de Valencia, Catedrático Agustin Escardino, 9, 46980, Paterna, Valencia
info@sabartech.com
EXPEDIENT Nº: IMIDTA/2023/43.
PROGRAM: SME R&D PROJECTS (PIDI-CV) 2023
PROJECT: AIG-SPORT – THE NEXT GENERATION OF SPORT PERFORMANCE (AIG-SPORT)
OBJECTIVES: The generation of a new model of 5P SPORTS TECHNOLOGY to revolutionise professional and amateur sport.
RESULTS ACHIEVED: A software focused on sports performance called AIG-SPORT that aims to bring science closer to athletes through guidelines for the improvement of sports performance, athletes’ brands, the prevention of injuries related to exercise and training, the personalisation of food and supplementation plans in a much more precise way.
THIS PROJECT IS SUPPORTED BY THE EUROPEAN UNION AS IT HAS BEEN SELECTED IN THE FEDER OPERATIONAL PROGRAMME FOR THE VALENCIAN COMMUNITY 2021-2027.
Expedient Nº: INNEST/2021/292
Project: INTELLIGENT PLATFORM FOR EARLY DETECTION, DIAGNOSIS AND MONITORING OF SARCOPENIA (iSARC-GENETICS)
Supported by Agència Valenciana de la Innovació (AVI)
